CID 11705594

Schembl3992178

Structural Information

Molecular Formula
C29H41N5O
SMILES
CC(C)N1CCC[C@@H](C1)CN2C3=CC=CC=C3N=C2CN(CCCO)[C@H]4CCCC5=C4N=CC=C5
InChI
InChI=1S/C29H41N5O/c1-22(2)32-16-7-9-23(19-32)20-34-26-13-4-3-12-25(26)31-28(34)21-33(17-8-18-35)27-14-5-10-24-11-6-15-30-29(24)27/h3-4,6,11-13,15,22-23,27,35H,5,7-10,14,16-21H2,1-2H3/t23-,27-/m0/s1
InChIKey
HNPRTVLVYBDBAL-HOFKKMOUSA-N
Compound name
3-[[1-[[(3S)-1-propan-2-ylpiperidin-3-yl]methyl]benzimidazol-2-yl]methyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]propan-1-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

475.33112 Da
Monoisotopic Mass

3.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 476.33840 219.9
[M+Na]+ 498.32034 221.0
[M-H]- 474.32384 223.6
[M+NH4]+ 493.36494 224.5
[M+K]+ 514.29428 213.6
[M+H-H2O]+ 458.32838 205.9
[M+HCOO]- 520.32932 228.2
[M+CH3COO]- 534.34497 223.7
[M+Na-2H]- 496.30579 216.8
[M]+ 475.33057 216.5
[M]- 475.33167 216.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe